Garry Christopher Harris, MD | |
8495 Crater Lake Hwy, Sorcc Ent Consultant, White City, OR 97503-3011 | |
(541) 286-2111 | |
(541) 830-3502 |
Full Name | Garry Christopher Harris |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 8495 Crater Lake Hwy, White City, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073524278 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD20881 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Garry Christopher Harris, MD 65 Fair Oaks Dr, Medford, OR 97504-7715 Ph: (541) 608-9151 | Garry Christopher Harris, MD 8495 Crater Lake Hwy, Sorcc Ent Consultant, White City, OR 97503-3011 Ph: (541) 286-2111 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.
Repros Therapeutics today announced the pricing of its public offering of 690,000 units, consisting of 2,760,000 shares of its common stock, Series A Warrants to purchase 2,070,000 shares of common stock and Series B Warrants to purchase 1,690,500 shares of its common stock, at a price per unit of $17.15.
In the meantime, Minnesota's hospitals saw their uncompensated care costs increase at the slowest rate in five years.
A retrospective study of almost 39,000 patients shows that opportunities to diagnose chronic obstructive pulmonary disease (COPD) at an earlier stage are frequently being missed in both primary and secondary care in the UK. The findings, published in The Lancet Respiratory Medicine, reveal missed opportunities to diagnose COPD occurred in up to 85% of people.
› Verified 9 days ago